CORDIS · 742654 · H2020
EpiTrack Single-cell temporal tracking of epigenetic DNA marks
Coordinator: VILNIAUS UNIVERSITETAS (LT)
Over the past decade, epigenetic phenomena have taken centre stage in our understanding of gene regulation, cellular differentiation and human disease. DNA methylation is a prevalent epigenetic modification in mammals, which is brought about by enzymatic transfer of methyl groups from the S-adenosylmethionine (SAM) cofactor by three known DNA methyltransferases (DNMTs). The most dramatic epigenomic reprogramming in mammalian development occurs after fertilization, whereby a global loss of DNA methylation is followed by massive reinstatement of new methylation patterns, different for each cell…
About Horizon 2020 (2014–2020)
Horizon 2020 was the EU's flagship research and innovation programme for 2014–2020, with a budget of around €77 billion. It bundled FP7's strands with the EIT and the Competitiveness and Innovation Programme, introduced a stronger societal-challenge orientation, and pushed the funding logic toward closer-to-market innovation. New calls closed in 2020 but funded projects continued through 2024.
EU contribution: €2.5M awarded to the consortium. The project runs over approximately 5.5 years from 2017-09-01 to 2023-02-28.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu → Grant DOI ↗More from LT
see all →- SustAInLivWork — Centre of Excellence of AI for Sustainable Living and Working101059903 · HORIZON · €14.7M
- SUPER PV — CoSt redUction and enhanced PERformance of PV systems792245 · H2020 · €9.9M
- Forest 4.0 — Creation of the centre of excellence in smart forestry101059985 · HORIZON · €9.9M
- FemtoSurf — Functional surface treatments using ultra-short pulse laser system FemtoSurf825512 · H2020 · €7.0M
- GIFFT — Sustainable Glass Industry with Fuel-Flexible Technology101122257 · HORIZON · €4.5M
- EnergyKeeper — Keep the Energy at the right place!731239 · H2020 · €4.0M
Other H2020 projects
see all →- EUROfusion — Implementation of activities described in the Roadmap to Fusion during Horizon 2020 through a Joint programme of the members of the EUROfusion consortium633053 · DE · €678.8M
- H2020 — COST at a turning point: A unique framework for pan-European ST cooperation as clear demonstration of European values681463 · BE · €178.2M
- HBP SGA3 — Human Brain Project Specific Grant Agreement 3945539 · BE · €150.0M
- COVID-19 VACCINES — PROPOSAL FOR FUNDING RESEARCH DEVELOPMENT AND MANUFACTURING OF VACCINE AGAINST COVID-19101018100 · NO · €100.0M
- UNITE4TB — ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS101007873 · NL · €92.5M
- ERA4TB — EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS853989 · ES · €89.8M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Horizon 2020 (2014–2020) programme, under the ERC-ADG funding scheme.
- What is the EU contribution?
- The European Commission contributes €2.5M toward a total project budget of €2.5M.
- Which EU programme funds it?
- The project is funded under Horizon 2020 (2014–2020), call ERC-2016-ADG.
- Who coordinates the project?
- The project is coordinated by VILNIAUS UNIVERSITETAS (LT).
- What is the project timeline?
- The project runs from 2017-09-01 to 2023-02-28 — approximately 5.5 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 742654.